Playback speed
10 seconds
ASH 2023 Insights: "Pirtobrutinib in Post-cBTKi CLL/SLL - 30 Months Follow-Up & Subgroup Analysis With/Without Prior BCL2i From the Ph1/2 BRUIN Study"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jennifer Woyach
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jennifer Woyach
326 views
December 19, 2023
Login to view comments.
Click here to Login